Copyright
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 28, 2017; 23(28): 5051-5067
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5051
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5051
Barrett’s oesophagus: Current controversies
Chidi Amadi, Piers Gatenby, Regional Oesophagogastric Unit, Royal Surrey County Hospital, Guildford GU2 7XX, United Kingdom
Author contributions: Amadi C constructed and wrote this paper; Gatenby P conceptualised the idea and reviewed the paper.
Conflict-of-interest statement: Amadi C and Gatenby P declare no conflicts of interest related to this publication.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Chidi Amadi, MBBS, BSc, Medical Doctor, Regional Oesophagogastric Unit, Royal Surrey County Hospital, Egerton Road, Guildford GU2 7XX, United Kingdom. chidi.amadi@nhs.net
Telephone: +44-1483-571122-2703 Fax: +44-1483-406636
Received: February 3, 2017
Peer-review started: February 8, 2017
First decision: March 3, 2017
Revised: April 3, 2017
Accepted: July 4, 2017
Article in press: July 4, 2017
Published online: July 28, 2017
Peer-review started: February 8, 2017
First decision: March 3, 2017
Revised: April 3, 2017
Accepted: July 4, 2017
Article in press: July 4, 2017
Published online: July 28, 2017
Core Tip
Core tip: Oesophageal adenocarcinoma is increasing in incidence especially in Western populations. Barrett’s oesophagus is the identifiable pre-malignant condition which allows periodic surveillance and secondary prevention to be undertaken to reduce cancer risk. There has been recent evidence supporting earlier endoscopic intervention for dysplastic changes in Barrett’s oesophagus, but the high burden of surveillance prompts increased efforts to identify individuals at highest cancer risk to concentrate resources on those patients who will derive the greatest benefit.